Güngör N, Tunçbilek E
Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara.
Turk J Pediatr. 1995 Apr-Jun;37(2):157-63.
A patient with enzymatically proven Sanfilippo disease type B is presented. This type of mucopolysaccharidosis results from deficient o-N-acetylglucosaminidase activity leading to defective degradation of heparan sulphate. As this disease is associated with high morbidity and mortality, different therapeutic approaches are under investigation. Bone marrow transplantation is among these new choices of management. The value of bone marrow transplantation in the mucopolysaccharidoses, especially in MPS IIIB, is discussed with a wide review of the literature.
本文介绍了一名经酶学证实为B型Sanfilippo病的患者。这种类型的黏多糖贮积症是由于α-N-乙酰氨基葡萄糖苷酶活性不足导致硫酸乙酰肝素降解缺陷所致。由于这种疾病与高发病率和高死亡率相关,目前正在研究不同的治疗方法。骨髓移植是这些新的治疗选择之一。本文通过广泛的文献综述,讨论了骨髓移植在黏多糖贮积症,特别是在MPS IIIB中的价值。